← Scroll for more →
Financial Statements — LIME
Balance Sheet
(in billions USD)| Metric | Q2 2026 |
|---|---|
| Cash & Equivalents | 0.28 |
| Accounts Receivable | 0.03 |
| Total Current Assets | 0.48 |
| Property, Plant & Equipment | 0.33 |
| Total Non-current Assets | 0.70 |
| Total Assets | 1.18 |
| Accounts Payable | 0.01 |
| Total Current Liabilities | 0.30 |
| Long-term Debt | 0.12 |
| Total Non-current Liabilities | 0.08 |
| Total Liabilities | 0.38 |
| Retained Earnings | (0.51) |
| Total Stockholder Equity | 0.68 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 |
|---|---|
| Total Revenue | 71.03 |
| Cost of Revenue | 175.17 |
| Gross Profit | 129.05 |
| Research & Development | 31.24 |
| Selling, General & Admin | 67.26 |
| Total Operating Expenses | 116.24 |
| Operating Income | 12.81 |
| Pretax Income | (3.05) |
| Tax Provision | (298.43) |
| Net Income | 295.38 |
| Basic EPS | 26.70 |
| Diluted EPS | 4.73 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | 49.29 |
| Capital Expenditures | 10.59 |
| Free Cash Flow* | 38.70 |
| Investing Cash Flow | (132.62) |
| Financing Cash Flow | 7.90 |
← Scroll for more columns →
* Derived from reported values